Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
Filter results of approved projects table below
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO | Hormuzd Katki | NCI | PLCO | Dec 8, 2021 | PLCO-875 |
| Using PRS for CRC screening | Ulrike Peters | Fred Hutchinson Cancer Research Center | PLCO | Dec 8, 2021 | PLCO-872 |
| Instrumental Variable Estimation of Complier Causal Treatment Effect with Interval-Censored Data | Jianguo Sun | University of Missouri-Columbia | PLCO | Nov 30, 2021 | PLCO-871 |
| Identifying risk factors for colorectal neoplasia through machine learning | Daniella Araujo | Universidade Federal de Minas Gerais | PLCO | Nov 30, 2021 | PLCO-870 |
| Melanoma Comorbidity Clusters | Vishnutheertha Kulkarni | Johns Hopkins University | PLCO | Nov 30, 2021 | PLCO-869 |
| Combining Classifier with Bagging for endometriosis prediction. | David Kilembwe | Independent | PLCO | Nov 22, 2021 | PLCO-861 |
| Using machine learning and big data for optimizing medication prescriptions for lung cancer | Jason Chang | National Yunlin University of Science and Technology | PLCO | Nov 22, 2021 | PLCO-859 |
| Modern Statistical Models and Artificial Intelligence for Early Detection of Disease with Longitudinal Biomarker | Tim Tobias Arndt | Universität Augsburg | PLCO | Nov 15, 2021 | PLCO-857 |
| Relationship between Socioeconomic Status, Obesity and Prevalence of Male Breast Cancer | Taye Olabode | Walden University | PLCO | Nov 5, 2021 | PLCO-854 |
| Robust and reliable Artificial Intelligence for oncology | Chiara Verdone | Università degli Studi del Sannio | PLCO | Nov 3, 2021 | PLCOI-851 |
| Identifying risk factors for breast cancer through machine learning | Daniella Araujo | Universidade Federal de Minas Gerais | PLCO | Nov 3, 2021 | PLCO-853 |
| Estrogen Exposure and Pancreatic Cancer Risk | Timothy Donahue | UCLA | PLCO | Nov 3, 2021 | PLCO-850 |
| Serum / plasma metabolomic profiling of vitamin supplement use | Demetrius Albanes | National Cancer Institute, NIH | PLCO | Nov 3, 2021 | PLCO-849 |
| Vitamin D Binding Protein Genetic Isoforms and Cancer Incidence in PLCO | Stephanie Weinstein | NCI | PLCO | Oct 29, 2021 | PLCO-846 |
| PLCO Data Modeling as RDF/JSON-LD | Jonas De Almeida | National Cancer Institute | PLCO | Oct 29, 2021 | PLCO-843 |
| Improving diagnosis, treatment approach, and quality-of-life of patients with prostate cancer using A.I. | Frank Sullivan | Galway Clinic | PLCO | Oct 29, 2021 | PLCO-842 |
| Epidemiologic investigation of breast cancer cases diagnosed in a large histopathological practice | Axel Niendorf | MVZ Prof. Dr. med. A. Niendorf Pathologie Hamburg-West GmbH | PLCO | Oct 29, 2021 | PLCO-841 |
| Ambient ultraviolet radiation and serum metabolites in the Prostate, Lung, Colorectal, and Ovarian Cancer Trial | Zhi-Ming Mai | Division of Cancer Epidemiology and Genetics, National Cancer Institute | PLCO | Oct 15, 2021 | PLCO-840 |
| Link between breast cancer and female lifestyle habits | Julia Mogren | Independent Researcher | PLCO | Oct 15, 2021 | PLCO-838 |
| Understanding genetic basis of cancer survival time using PLCO GWAS | Kai Yu | NCI | PLCO | Oct 15, 2021 | PLCO-845 |